Advertisement
Screener

BIOCRYST PHARMACEUTICALS, INC. (BCRX) ROA

BIOCRYST PHARMACEUTICALS, INC. (BCRX) ROA

  • 2026-06-30: ROA -68.96%.
  • 2026-03-31: ROA -98.48%.
  • 2025-12-31: ROA 51.32%.
  • 2025-09-30: ROA -1.97%.

Complete source-backed roa history.

Available history
2010-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-68.96%
2026-03-31-98.48%
2025-12-3151.32%
2025-09-30-1.97%
2025-06-30-7.81%
2025-03-31-11.14%
2024-12-31-18.12%
2024-09-30-25.20%
2024-06-30-30.89%
2024-03-31-44.58%
2023-12-31-43.82%
2023-09-30-45.20%
2023-06-30-45.81%
2023-03-31-44.39%
2022-12-31-44.93%
2022-09-30-34.61%
2022-06-30-41.06%
2022-03-31-36.76%
2021-12-31-31.30%
2021-09-30-85.33%
2021-06-30-77.21%
2021-03-31-73.66%
2020-12-31-54.62%
2020-09-30-70.90%
2020-06-30-54.22%
2020-03-31-84.52%
2019-12-31-62.13%
2019-09-30-147.74%
2019-06-30-108.05%
2019-03-31-74.84%
2018-12-31-68.95%
2018-09-30-55.47%
2018-06-30-57.74%
2018-03-31-49.78%
2017-12-31-36.90%
2017-09-30-26.50%
2017-06-30-41.53%
2017-03-31-35.93%
2016-12-31-61.38%
2016-09-30-75.16%
2016-06-30-87.41%
2016-03-31-49.27%
2015-12-31-35.16%
2015-09-30-26.31%
2015-06-30-20.42%
2015-03-31-38.67%
2014-12-31-33.02%
2014-09-30-28.40%
2014-06-30-26.92%
2014-03-31-82.37%
2013-12-31-61.61%
2013-09-30-67.16%
2013-06-30-93.77%
2013-03-31-80.03%
2012-12-31-68.04%
2012-09-30-64.31%
2012-06-30-60.31%
2012-03-31-62.40%
2011-12-31-69.27%
2011-09-30-58.33%
2011-06-30-46.46%

Annual ROA

DateROA
2025-12-3151.32%
2024-12-31-18.12%
2023-12-31-43.82%
2022-12-31-44.93%
2021-12-31-31.30%
2020-12-31-54.62%
2019-12-31-62.13%
2018-12-31-68.95%
2017-12-31-36.90%
2016-12-31-61.38%
2015-12-31-35.16%
2014-12-31-33.02%
2013-12-31-61.61%
2012-12-31-68.04%
2011-12-31-69.27%
2010-12-31-30.93%

Similar stocks

Stock NameCountryMarket CapPE Ratio
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Greenland Mines Ltd (GRML)United States$2.362B
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43